Overexpression of α1,6-fucosyltransferase in hepatoma enhances expression of Golgi phosphoprotein 2 in a fucosylation-independent manner

International Journal of Oncology

Volumn 39, Issue 1, 2011, Pages 203-208

  Kawamoto, Sayuri ^a   Moriwaki, Kenta ^a   Nakagawa, Tsutomu ^a   Terao, Mika ^a   Shinzaki, Shinichtro ^a   Yamane Ohnuki, Naoko ^b   Satoh, Mitsuo ^b   Mehta, Anand S ^c   Block, Timothy M ^c   Eiji, Miyoshi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Fucosylation; Fut8; GP73; HCC; Oligosaccharide

Indexed keywords

ALPHA 1,6 FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE; GOLGI PHOSPHOPROTEIN 2; OLIGOSACCHARIDE; PHOSPHOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; FUCOSYLATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CRICETINAE; FUCOSYLTRANSFERASES; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; INTRACELLULAR SPACE; LIVER NEOPLASMS; MEMBRANE PROTEINS; MUTATION; PROTEIN TRANSPORT; SEQUENCE ALIGNMENT; TRANSFECTION;

EID: 79956052012     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1005     Document Type: Article

References (24)

1. Kladney RD, Bulla GA, Guo L, et al: GP73, a novel Golgi-localized protein upregulated by viral infection. Gene 249: 53-65, 2000. (Pubitemid 30300752)
2. Kladney RD, Cui X, Bulla GA, Brunt EM and Fimmel CJ: Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology 35: 1431-1440, 2002. (Pubitemid 34966897)
3. Iftikhar R, Kladney RD, Havlioglu N, et al: Disease- and cell-specific expression of GP73 in human liver disease. Am J Gastroenterol 99: 1087-1095, 2004. (Pubitemid 38917813)
4. Marrero JA, Romano PR, Nikolaeva O, et al: GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinomas. Hepatology 43: 1007-1012, 2005. (Pubitemid 41627986)
5. Riener MO, Stenner F, Liewen H, et al: Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology 49: 1602-1609, 2009.
6. Wang M, Long RE, Comunale MA, et al: Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 99: 939-948, 2009.
7. Gu Y, Chen W, Zhao Y, Chen L and Peng T: Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases. Ann Clin Biochem 46: 38-43, 2009.
8. Block TM, Comunale MA, Lowman M, et al: Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci USA 102: 779-784, 2005. (Pubitemid 40282742)
9. Norton PA, Comunale MA, Krakover J, et al: N-linked glycosylation of the liver cancer biomarker GP73. J Cell Biochem 104: 136-149, 2008.
10. Miyoshi E, Moriwaki K and Nakagawa T: JB Minireview-Biological function of fucosylation in cancer biology. J Biochem 143: 725-729, 2008. (Pubitemid 351918934)
11. Noda K, Miyoshi E, Uozumi N, et al: Gene expression of alpha 1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein. Hepatology 28: 944-952, 1998. (Pubitemid 28450254)
12. Miyoshi E, Noda K, Ko JH, et al: Overexpression of α1-6 fucosyl-transferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice. Cancer Res 59: 2237-2243, 1999. (Pubitemid 29217691)
13. Wang X, Inoue S, Gu J, et al: Dysregulation of TGF-β1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc Natl Acad Sci USA 102: 15791-15796, 2005. (Pubitemid 41552821)
14. Noda K, Miyoshi E, Gu J, et al: Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines. Cancer Res 63: 6282-6289, 2003. (Pubitemid 37255175)
15. Moriwaki K, Noda K, Nakagawa T, et al: A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation. Glycobiology 17: 1311-1320, 2007. (Pubitemid 350138979)
16. Yamane-Ohnuki N, Kinoshita S, Inoue-Urakubo M, et al: Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. Biotechnol Bioeng 87: 614-622, 2004 (Pubitemid 39295406)
17. Yamashita K, Kochibe N, Ohkura T, Ueda I and Kobata A: Fractionation of L-fucose-containing oligosaccharides on immobilized Aleuria aurantia lectin. J Biol Chem 260: 4688-4693, 1985. (Pubitemid 15034604)
18. Miyoshi E, Ihara Y, Hayashi N, Fusamoto H, Kamada T and Taniguchi N: Transfection of N-acetylglucosaminyltransferase III gene suppresses expression of hepatitis B virus in a human hepatoma cell line, HB611. J Biol Chem 270: 28311-28315, 1995.
19. Aoyagi Y, Suzuki Y, Igarashi K, et al: The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer 67: 2390-2394, 1991.
20. Taketa K, Endo Y, Sekiya C, et al: A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res 53: 5419-5423, 1993.
21. Okuyama N, Ide Y, Nakano M, et al: Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer 118: 2803-2808, 2006. (Pubitemid 43673360)
22. Miyoshi E and Nakano M: Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures. Proteomics 8: 3257-3262, 2008.
23. Moriwaki K, Noda K, Furukawa Y, et al: Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling. Gastroenterology 137: 188-198, 2009.
24. Yoshida H: ER stress response, peroxisome proliferation, mitochondrial unfolded protein response and Golgi stress response. IUBMB Life 61: 871-879, 2009.